STK11 and metabolic dysfunction-associated steatotic liver disease: Mechanistically, RNA sequencing (RNA-seq) analysis revealed that tranilast combats hepatic lipid accumulation in NAFLD by deacetylating liver kinase B1 (LKB1) and promoting AMP-activated protein kinase (AMPK) activation.